Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News EuroPCR 2016

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Yael L. Maxwell

May 18, 2016

News Conference News EuroPCR 2016

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

Caitlin E. Cox

May 17, 2016

News Conference News EuroPCR 2016

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Shelley Wood

May 16, 2016

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Caitlin E. Cox

May 23, 2014

Presentation EuroPCR 2014

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

May 22, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

News Conference News EuroPCR 2014

EuroPCR Features PAD Therapies in Early Development and Real-World Use

Caitlin E. Cox

May 21, 2014

Presentation EuroPCR 2013

The Next Generation Renal Denervation Technology - The Vessix Device

Presenter: E. Wyffels

May 31, 2013

Presentation EuroPCR 2013

Clinical evidence in catheter-based renal sympathetic denervation - building the data

Presenter: 161082|Joachim Schofer

May 31, 2013

News Conference News EuroPCR 2013

Paclitaxel Delivery Key to PAD Intervention

Caitlin E. Cox

May 22, 2013

News Conference News EuroPCR 2012

TAVR Studies Tease Out Influences on Clinical Outcome

Caitlin E. Cox

May 18, 2012

News Conference News EuroPCR 2012

Radial Approach Paving the Way to Better Outcomes in Acute MI Patients

Jason Kahn

May 18, 2012

News Conference News

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

May 23, 2011

News Conference News

Osmolality, Viscosity Make No DIRECT Difference in Contrast Nephropathy

Jason Kahn

May 18, 2011

Advertisement

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

EuroPCR Features PAD Therapies in Early Development and Real-World Use

The Next Generation Renal Denervation Technology - The Vessix Device

Clinical evidence in catheter-based renal sympathetic denervation - building the data

Paclitaxel Delivery Key to PAD Intervention

TAVR Studies Tease Out Influences on Clinical Outcome

Radial Approach Paving the Way to Better Outcomes in Acute MI Patients

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

Osmolality, Viscosity Make No DIRECT Difference in Contrast Nephropathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content